GHP Q1 2024

8 GHP Q1 2024 It is the mission of Byomed LLC to provide patients with care of the highest calibre, using only the best technology, systems, and materials to provide a complete and superior medical experience.The overarching aim of the company is to manage a patient’s overall wellbeing with the uppermost effectiveness so as to deliver unrivalled services across its areas of operation. Conveniently, the primary area of operation is the operating theatre, which is too the setting where the company’s distinction is felt the most, serving those suffering with degenerative spine conditions. CEO and Founder Tarek Hamandi tells us more about the business’ stellar and innovative solutions. Having performed more than 3200 open spine and total joint surgeries in the State of Florida since 2007, Tarek Hamandi knows a great deal about the industry and the most viable solutions that can immeasurably benefit the lives of patients. A pioneer in the field of BMAC (Bone Marrow Aspiration Concentrate) injections, Tarek has leveraged this expertise into the creation of three successful businesses that provide spinal an orthopedic surgeons with the latest in innovative technologies. One procedure that has been mastered by the team at Byomed is the extracting and mixing of cadaver bone with a patient’s own stem cells, the undertaking of which having been shown to improve the effectiveness of a surgery. As Tarek eloquently states, “our goal is to provide spine surgeons with the best and unique solutions tailored to their patients.” There are four key services that serve as the company putting this ethos into action, the first of which being an autotransfusion, which uses technology to enable a person to receive their own blood from a transfusion, rather than somebody else’s. Blood is either donated beforehand by the patient, or it can be collected during a surgery by a piece of kit called a Cell Saver. The Cell Saver is primarily used during surgeries where a high volume of blood loss is likely to be experienced, such as aneurysms, joint replacements, and spine surgeries. The second key component comprising this quartet of services is bone marrow aspirate concentrate. This product is produced by the company using Harvest Technologies Terumo BCT., and acts as the most essential element in facilitating the growth of new bone, combining it with the bone grafts already held by the by the company to yield optimal results. A unique process that has been developed by the business allows it to keep the aspirate bone marrow sterile across the entire procedure, significantly minimising infection risk. A game-changing service available to fellow surgeons and patients alike, this concentrate is one of Byomed’s premier offerings and arguably the one it is proudest of. Yet another solution on offer by Byomed is platelet-rich plasma (PRP), with this simply being blood plasma enriched by platelets for the purposes of accelerating healing by using a patient’s own blood cells. Since the platelet component of blood is comprised of a series of key and essential factors that aid in hard and soft tissue repair, as well as contributing to stem cell migration, PRP has a history of being used effectively in tendon surgeries of all sorts, inclusive of knee replacements, tennis elbow surgeries, and even some oral-based surgeries. Finally, Byomed’s allograft service revolves around the company’s biomaterials providing demineralised cadaver bone strips, bone chips, bone putty, putty crush-mix, and sponges in an array of shapes and sizes for various parts of the body. Not only are such bone grafts a safe and reliable alternative, but they are also ideal for those patients who either do not have bone suitable for grafting or do not wish to undergo the extensive procedure necessary to get it, since it is a complicated operation that brings with it considerable risk. Through these pioneering solutions, Byomed is continuously demonstrating its excellence in the field, something that is set to continue this year, with the team having patients from Middle Eastern countries, such as the UAE, Kuwait, and Qatar, with complex surgical needs brought into its South Florida surgery beginning in July. This worldwide reach serves as one of the ways that the company is seeking to differentiate itself in a growing industry where innovation and uniquity are paramount. As Tarek explains in summary, “we are actively investing in medical technology, [as] taking higher risks than others is key.” With such commitments to boot, Byomed LLC is sure to continue down this pioneering path, and we await the future ways that Tarek influences the wider sector, setting patients down the path to health. Contact: Tarek Hamandi Company: Byomed LLC Web Address: https://byomed.com/ Stem Cells & Auto-Transfusion Solutions 2023 - Florida

RkJQdWJsaXNoZXIy MTUyMDQwMA==